Form D Explorer

Source evidence

BridgeHealth Pharmaceuticals, Inc. · 0002162724-26-000001

D filed Nov. 5, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
WOBURN
street1
400 TRADECENTER
street2
SUITE #5900
zipCode
01801
entityName
BridgeHealth Pharmaceuticals, Inc.
entityType
Corporation
stateOrCountry
MA
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold3500000number3500000/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount3500000number3500000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count5number5/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 84b161264668b8257cf597aa9991d31182ce4106c72e729a1d53f681f4fb1959. This proves extraction identity, not the accuracy of the filer's claims.